- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Glycogen Storage Disease Type II in Taiwan
Total 1677 results
-
Amicus TherapeuticsRecruitingGlycogen Storage Disease Type II Infantile OnsetUnited States, Taiwan, France, Germany, Italy, United Kingdom
-
Genzyme, a Sanofi CompanyActive, not recruitingGlycogen Storage Disease Type II-Pompe's DiseaseUnited States, France, Japan, Taiwan, United Kingdom
-
Taipei Veterans General Hospital, TaiwanUnknownGlycogen Storage Disease Type IITaiwan
-
Genzyme, a Sanofi CompanyTerminatedGlycogenosis 2 | Glycogen Storage Disease Type II (GSD II) | Acid Maltase Deficiency | Pompe Disease (Infantile-Onset)United States, Taiwan, Germany
-
National Taiwan University HospitalUnknown
-
National Taiwan University HospitalUnknown
-
National Taiwan University HospitalRecruiting
-
National Taiwan University HospitalRecruiting
-
National Taiwan University HospitalCompleted
-
National Taiwan University HospitalUnknown
-
National Taiwan University HospitalCompleted
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II;Pompe's DiseaseCzechia, Taiwan, Belgium, Germany, Korea, Republic of, United States, Argentina, Australia, Austria, Brazil, Canada, Denmark, France, Hungary, Italy, Japan, Mexico, Netherlands, Poland, Portugal, Russian Federation, Spain, Switzerland, Turk... and more
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type IIUnited States, France, Germany, Israel, Italy, Netherlands, Taiwan
-
LMU KlinikumGenzyme, a Sanofi CompanyCompletedPompe DiseaseGermany, Taiwan, Italy
-
Amicus TherapeuticsAvailablePompe Disease Infantile-OnsetTaiwan, United States, Italy
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type IIUnited States, Taiwan, Israel, United Kingdom, France
-
SanofiRecruitingGlycogen Storage Disease Type IIBelgium, United States, Italy, Spain, Taiwan, United Kingdom, Netherlands, France, Germany
-
SanofiRecruitingGlycogen Storage Disease Type IIBelgium, United States, China, Germany, Italy, Netherlands, Spain, Taiwan, United Kingdom
-
Astellas Gene TherapiesRecruitingPompe Disease (Late-onset)United States, Spain, France, Taiwan, Italy
-
Genzyme, a Sanofi CompanyCompletedPompe DiseaseBelgium, United States, Czechia, Germany, Italy, Taiwan
-
Amicus TherapeuticsRecruitingPompe Disease (Late-onset)United States, Taiwan, Japan, Australia, Canada
-
BioMarin PharmaceuticalTerminatedLate-onset Pompe Patients Untreated or Treated With rhGAASpain, Slovenia, Serbia, Korea, Republic of, Greece, Australia, Singapore, Brazil, Canada, Taiwan, Ireland, Poland, Romania
-
Amicus TherapeuticsActive, not recruitingPompe Disease (Late-onset)United States, Germany, Taiwan, Belgium, Australia, Slovenia, Spain, Netherlands, Hungary, Japan, Austria, United Kingdom, France, Argentina, Canada, Sweden, Denmark, New Zealand, Greece, Korea, Republic of, Bosnia and Herzegovina, Ita... and more
-
Amicus TherapeuticsCompletedPompe Disease (Late-onset)United States, Australia, Korea, Republic of, Japan, Taiwan, Belgium, Slovenia, New Zealand, United Kingdom, France, Argentina, Canada, Spain, Bosnia and Herzegovina, Germany, Sweden, Hungary, Austria, Bulgaria, Denmark, Greece, I... and more
-
Genzyme, a Sanofi CompanyRecruitingGlycogen Storage Disease Type II | Pompe DiseaseHungary, Croatia, Serbia, United States, Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Denmark, France, Germany, Greece, Hong Kong, India, Indonesia, Israel, Italy, Japan, Jordan, Korea, Republic of, Kuwait and more
-
National Cheng-Kung University HospitalMinistry of Science and Technology, TaiwanRecruitingBipolar II DisorderTaiwan
-
Microbio Co LtdCompleted
-
AstraZenecaCompletedType II Diabetes MellitusTaiwan
-
National Taiwan University HospitalRecruitingAutoimmune Polyendocrine Syndrome Type IITaiwan
-
Astellas Pharma IncCompletedType II Diabetes MellitusTaiwan, Korea, Republic of
-
Astellas Pharma IncTerminatedA Study to Assess the Efficacy and Safety of ASP1941 in Asian Subjects With Type 2 Diabetes MellitusType II Diabetes MellitusTaiwan, Korea, Republic of
-
National Health Research Institutes, TaiwanChina Medical University Hospital; Kaohsiung Medical University Chung-Ho Memorial... and other collaboratorsRecruitingPhase II, Open-label, Parallel 2-arm, Multi-centerTaiwan
-
Pharmasaga Co. Ltd.Recruiting
-
Celio Technology Inc.CompletedType II Diabetes MellitusTaiwan
-
Taichung Veterans General HospitalUnknownDiabetes MellitusTaiwan
-
ECbiotech TaiwanCompletedThe Supplementary Effects of the Extract of Agaricus Blazei Murril on Type II Diabetes Mellitus (DM)Diabetes Mellitus, Type IITaiwan
-
SanofiRecruiting
-
Global Preventive Medicine Biotech Co., Ltd.Completed
-
Chimei Medical CenterKaohsiung Medical UniversityRecruitingDiabetes Mellitus Type 2 With Periodontal DiseaseTaiwan
-
Ping-Yen LiuUnknownChronic Kidney Disease | Acute Coronary Syndrome | End-Stage Renal DiseaseTaiwan
-
Min-Sheng General HospitalUnknownType II Diabetes MellitusTaiwan
-
GenMont Biotech IncorporationCompleted
-
National Cheng-Kung University HospitalUnknown
-
National Cheng-Kung University HospitalCompletedDiabetes Mellitus | ExerciseTaiwan
-
Taipei Medical University WanFang HospitalHi-Q Marine Biotech International, Ltd.Unknown
-
National Cheng-Kung University HospitalCompletedDiabetes Mellitus | Arteriovenous Fistula | End-stage Kidney DiseaseTaiwan
-
National Cheng-Kung University HospitalUnknown
-
G&E Herbal Biotechnology Co., LTDCompletedActinic Keratosis | Bowen's DiseaseTaiwan
-
Glac Biotech Co., LtdRecruitingChronic Obstructive Pulmonary Disease | Type 2 DiabetesTaiwan